Gossamer Bio, Inc. announced that Luisa Salter-Cid will join its executive management team as Chief Scientific Officer. Dr. Salter-Cid will lead the company’s research and preclinical development efforts. Dr. Salter-Cid brings to Gossamer Bio over 20 years of drug discovery experience in the biotech and pharmaceutical industries. She spent the last 13 years at Bristol Myers Squibb in increasing positions of responsibility, including Vice President and Head of Immunology, small molecule Immuno-Oncology and Genomics Discovery. In this position, she oversaw several biology groups that focused on target validation and development of innovative biologic and small-molecule therapeutics to address significant unmet needs in autoimmune diseases and cancer.